These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 128509)

  • 21. [Dosimetry problems in irradiation of mediastinal tumours (author's transl)].
    Tosi G; Borasi G; Botturi M
    Radiol Med; 1977 May; 63(5):417-24. PubMed ID: 413166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Foundation of the Ellis-formula (author's transl)].
    Kellerer AM
    Strahlentherapie; 1977 Jun; 153(6):384-92. PubMed ID: 877975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Radiobiologic principles of radiotherapy with special reference to the treatment with corpuscular radiation].
    Trott KR
    Strahlentherapie; 1974 Nov; 148(5):451-62. PubMed ID: 4216989
    [No Abstract]   [Full Text] [Related]  

  • 24. Remarks about fractionation schemes.
    Wideröe R
    Strahlentherapie; 1979 Oct; 155(10):666-72. PubMed ID: 494338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of electron contamination to the skin dose in teletherapy with Co-60 gamma-rays.
    Kulkarni RN
    Strahlentherapie; 1980; 156(10):694-6. PubMed ID: 7434375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dosimetric analysis of methods of irradiating bladder tumors].
    Pospelova II
    Med Radiol (Mosk); 1975 Feb; 20(2):12-5. PubMed ID: 805887
    [No Abstract]   [Full Text] [Related]  

  • 27. Some aspects of the chronological dose distribution in the radiobiology and radiotherapy.
    Ulmer W
    Strahlenther Onkol; 1986 Jun; 162(6):374-86. PubMed ID: 3738738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [How tolerant are partial dose values? Some additional remarks on the concept of a tolerance dose].
    Jensen JM; Melchert UH; Ihnen E
    Strahlenther Onkol; 1992 Nov; 168(11):640-5. PubMed ID: 1455292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of the NSD-concept for the ascertainment of tolerance doses in the region of the lung (author's transl)].
    Herrmann Th; Voigtmann L; Ehrhardt M; Eberhardt HJ; Strietzel M
    Strahlentherapie; 1979 Jan; 155(1):10-4. PubMed ID: 760269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of dose distribution for oblique incidence in 6 mv x-rays therapy.
    Obata Y; Okumura Y
    Strahlentherapie; 1976 Nov; 152(5):443-8. PubMed ID: 825994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nominal standard dose and tumor standard dose. Tables for radiation therapy planning and analysis.
    Kuisk H; Khan FM
    Acta Radiol Ther Phys Biol; 1975; (345 suppl):1-151. PubMed ID: 1234821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical experience with proton beam radiation therapy.
    Suit HD; Goitein M; Munzenrider JE; Verhey L; Gragoudas E; Koehler AM; Urano M; Shipley WU; Linggood RM; Friedberg C; Wagner M
    J Can Assoc Radiol; 1980 Mar; 31(1):35-9. PubMed ID: 6245096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractionated irradiation of five human lung cancer cell lines and prediction of survival according to a radiobiology model.
    Hedman M; Bergqvist M; Brattström D; Brodin O
    Anticancer Res; 2011 Apr; 31(4):1125-30. PubMed ID: 21508355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential of californium-252 in radiotherapy. Preclinical measurements in physics and radiobiology.
    Hall EJ; Rossi H
    Br J Radiol; 1975 Oct; 48(574):777-90. PubMed ID: 811295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative biological effectiveness of low- and high-LET radiotherapy beams for jejunal crypt cell survival at low doses per fraction.
    Fu KK; Phillips TL; Heilbron DC; Ross G; Kane LJ
    Radiology; 1979 Jul; 132(1):205-9. PubMed ID: 109900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiobiologic parameters and local effect model predictions for head-and-neck squamous cell carcinomas exposed to high linear energy transfer ions.
    Beuve M; Alphonse G; Maalouf M; Colliaux A; Battiston-Montagne P; Jalade P; Balanzat E; Demeyer A; Bajard M; Rodriguez-Lafrasse C
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):635-42. PubMed ID: 18234427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of high LET facilities, existing and projected, with emphasis on the radiobiologic aspects.
    Hall EJ
    J Can Assoc Radiol; 1975 Mar; 26(1):3-14. PubMed ID: 806598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system.
    Stuschke M; Budach V; Stüben G; Streffer C; Sack H
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):395-408. PubMed ID: 7751182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of a valuable biochemical indicator in radiotherapy. III. Serum lactate dehydrogenase enzyme level on irradiation of cancer patients.
    Horváth M; Rodé IL; Kralovánszky J; Volant M
    Strahlentherapie; 1980 Apr; 156(4):244-7. PubMed ID: 7368229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quantitative analysis of treatment programs using various types of irradiation].
    Wideröe R
    Strahlentherapie; 1969 Mar; 137(3):292-9. PubMed ID: 4980749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.